An essential E box in the promoter of the gene encoding the mRNA cap- binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc

Molecular and Cellular Biology

Volumn 16, Issue 9, 1996, Pages 4754-4764

  Jones, Robin M ^a,b   Branda, John ^a   Johnston, Kelly A ^a   Polymenis, Michael ^a   Gadd, Michele ^a,b   Rustgi, Anil ^a,b   Callanan, Larry ^a,c   Schmidt, Emmett V ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; INITIATION FACTOR 4E; MESSENGER RNA;

ARTICLE; BINDING SITE; DNA BINDING; GENE EXPRESSION REGULATION; HELA CELL; NONHUMAN; NUCLEOTIDE REPEAT; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS; REPORTER GENE; TRANSCRIPTION INITIATION;

EUKARYOTA;

EID: 0029772318     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.9.4754     Document Type: Article

References (72)

1. Adams, J. M., and S. Cory. 1991. Transgenic models of tumor development. Science 254:1161-1167.
2. Adams, J. M., A. W. Harris, C. A. Pinkert, L. M. Corcoran, W. S. Alexander, S. Cory, R. D. Palmiter, and R. L. Brinster. 1985. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature (London) 318:533-538.
3. Amati, B., M. W. Brooks, N. Levy, T. D. Littlewood, G. I. Evan, and H. Land. 1993. Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell 72:233-245.
4. Amati, B., S. Dalton, M. W. Brooks, T. D. Littlewood, G. I. Evan, and H. Land. 1992. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature (London) 359:423-426.
5. Amati, B., T. D. Littlewood, G. I. Evan, and H. Land. 1993. The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J. 12:5083-5087.
6. Auvinen, M., A. Paasinen, L. C. Andersson, and E. Holtta. 1992. Ornithine decarboxylase activity is critical for cell transformation. Nature (London) 360:355-358.
7. Beckmann, H., L. K. Su, and T. Kadesch. 1990. TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer muE3 motif. Genes Dev. 4:167-179.
8. Bello-Fernandez, C., G. Packham, and J. L. Cleveland. 1993. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl. Acad. Sci. USA 90:7804-7808.
9. 2 on specificity and comparison with binding of Myc family members. Nucleic Acids Res. 22:2801-2810.
10. Benvenisty, N., A. Leder, A. Kuo, and P. Leder. 1992. An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence. Genes Dev. 6:2513-2523.
11. Bernards, R. 1991. N-myc disrupts protein kinase C-mediated signal transduction in neuroblastoma. EMBO J. 10:1119-1125.
12. Blackwell, T. K., J. Huang, A. Ma, L. Kretzner, F. W. Alt, R. N. Eisenman, and H. Weintraub. 1993. Binding of Myc proteins to canonical and noncanonical DNA sequences. Mol. Cell. Biol. 13:5216-5224.
13. Blackwell, T. K., L. Kretzner, E. M. Blackwood, R. N. Eisenman, and H. Weintraub. 1990. Sequence-specific DNA binding by the c-Myc protein. Science 250:1149-1151.
14. Blackwood, E. M., and R. N. Eisenman. 1991. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251:1211-1217.
15. Blackwood, E. M., B. Luscher, and R. N. Eisenman. 1992. Myc and Max associate in vivo. Genes Dev. 6:71-80.
16. Brenner, C., N. Nakayama, M. Goebl, K. Tanaka, A. Toh-e, and K. Matsumoto. 1988. CDC33 encodes mRNA cap-binding protein cIF4E of Saccharomyces cerevisiae. Mol. Cell. Biol. 8:3556-3559.
17. Carey, J. 1988. Gel retardation at low pH resolves trp repressor-DNA complexes for quantitative study. Proc. Natl. Acad. Sci. USA 85:975-979.
18. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease activity. Biochemistry 18:5294-5299.
19. Collum, R. G., and F. W. Alt. 1990. Are myc proteins transcription factors? Cancer Cells 2:69-75.
20. Dang, C. V. 1991. c-myc oncoprotein function. Biochim. Biophys. Acta 1072: 103-113.
21. Davis, A. C., M. Wims, G. D. Spotts, S. R. Hann, and A. Bradley. 1993. A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev. 7:671-682.
22. Dignam, J. D., R. M. Lebowitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
23. Downs, K. M., G. R. Martin, and J. M. Bishop. 1989. Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo. Genes Dev. 3:860-869.
24. Du, H., A. L. Roy, and R. G. Roeder. 1993. Human transcription factor USF stimulates transcription through the initiator elements of the HIV-1 and the Ad-ML promoters. EMBO J. 12:501-511.
25. Duncan, R., and J. W. Hershey. 1985. Regulation of initiation factors during translational repression caused by serum depletion. Abundance, synthesis, and turnover rates. J. Biol. Chem. 260:5486-5492.
26. Duncan, R., S. C. Milburn, and J. W. Hershey. 1987. Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4F suggest a role in translational control. Heat shock effects on eIF-4F. J. Biol. Chem. 262:380-388.
27. Eilers, M., S. Schirm, and J. M. Bishop. 1991. The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J. 10:133-141.
28. Fisher, D. E., C. S. Carr, L. A. Parent, and P. A. Sharp. 1991. TFEB has DNA-binding and oligomerization properties of a unique helix-loop-helix/ leucine-zipper family. Genes Dev. 5:2342-2352.
29. Fisher, F., D. H. Crouch, P. S. Jayaraman, W. Clark, D. A. Gillespie, and C. R. Goding. 1993. Transcription activation by Myc and Max: flanking sequences target activation to a subset of CACGTG motifs in vivo. EMBO J. 12:5075-5082.
30. Gaubatz, S., A. Meichle, and M. Eilers. 1994. An E-box element localized in the first intron mediates regulation of the prothymosin α gene by c-myc. Mol. Cell. Biol. 14:3853-3862.
31. Gu, W., K. Cechova, V. Tassi, and R. Dalla-Favera. 1993. Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. Proc. Natl. Acad. Sci. USA 90:2935-2939.
32. Heikkila, R., G. Schwab, E. Wickstrom, S. L. Loke, D. H. Pluznik, R. Watt, and L. M. Neckers. 1987. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1. Nature (London) 328:445-449.
33. Hershey, J. W. 1991. Translational control in mammalian cells. Annu. Rev. Biochem. 60:717-755.
34. Jaramillo, M., J. Pelletier, I. Edery, P. J. Nielsen, and N. Sonenberg. 1991. Multiple mRNAs encode the murine translation initiation factor eIF4E. J. Biol. Chem. 266:10446-10451.
35. Kaddurah-Daouk, R., J. M. Greene, A. S. Baldwin, Jr., and R. E. Kingston. 1987. Activation and repression of mammalian gene expression by the c-myc protein. Genes Dev. 1:347-357.
36. Kang, H. A., and J. W. Hershey. 1994. Effect of initiation factor eIF-5A depletion on protein synthesis and proliferation of Saccharomyces cerevisiae. J. Biol. Chem. 269:3934-3940.
37. Kato, G. J., J. Barrett, M. Villa-Garcia, and C. V. Dang. 1990. An amino-terminal c-Myc domain required for neoplastic transformation activates transcription. Mol. Cell. Biol. 10:5914-5920.
38. Kato, G. J., W. M. Lee, L. L. Chen, and C. V. Dang. 1992. Max: functional domains and interaction with c-Myc. Genes Dev. 6:81-92.
39. Kaulen, H., P. Pognonec, P. D. Gregor, and R. G. Roeder. 1991. The Xenopus B1 factor is closely related to the mammalian activator USF and is implicated in the developmental regulation of TFIHA gene expression. Mol. Cell. Biol. 11:412-424.
40. Kelly, K., B. H. Cochran, C. D. Stiles, and P. Leder. 1983. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35:603-610.
41. Klein, P. S., and D. A. Melton. 1994. Induction of mesoderm in Xenopus laevis embryos by translation initiation factor 4E. Science 365:803-806.
42. Koromilas, A. E., A. Lazaris-Karatzas, and N. Sonenberg. 1992. mRNAs containing extensive secondary structure in their 5′ non-coding region translate efficiently in cells overexpressing initiation factor eIF4E. EMBO J. 11:4153-4158.
43. Kretzner, L., E. M. Blackwood, and R. N. Eisenman. 1992. Myc and Max proteins possess distinct transcriptional activities. Nature (London) 359:426-429.
44. Land, H., L. F. Parada, and R. A. Weinberg. 1983. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (London) 304:596-602.
45. Lazaris-Karatzas, A., K. S. Montine, and N. Sonenberg. 1990. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature (London) 345:544-547.
46. Lazaris-Karatzas, A., M. R. Smith, R. M. Frederickson, M. L. Jaramillo, Y. L. Liu, H. F. Kung, and N. Sonenberg. 1992. Ras mediates translation initiation factor 4E-induced malignant transformation. Genes Dev. 6:1631-1642.
47. Leder, P., J. Battey, G. Lenoir, C. Moulding, W. Murphy, H. Potter, T. Stewart, and R. Taub. 1983. Translocations among antibody genes in human cancer. Science 222:765-771.
48. Lewin, B. 1991. Oncogenic conversion by regulatory changes in transcription factors. Cell 64:303-312.
49. Li, L. H., C. Nerlov, G. Prendergast, D. MacGregor, and E. B. Ziff. 1994. c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J. 13:4070-4079.
50. Littlewood, T. D., B. Amati, H. Land, and G. I. Evan. 1992. Max and c-Myc/Max DNA-binding activities in cell extracts. Oncogene 7:1783-1792.
51. Luckow, B., and G. Schutz. 1987. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15:5490.
52. 1/S-phasc boundary is suppressed by inhibitory c-Myc mutants. Mol. Cell. Biol. 15:2527-2535.
53. Murre, C., P. S. McCaw, and D. Baltimore. 1989 A new DNA binding dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56:777-783.
54. Pardee, A. B. 1989. G1 events and regulation of proliferation. Science 246: 603-608.
55. Park, M. H., E. C. Wolff, and J. E. Folk. 1993. Is hypusine essential for eukaryotic cell proliferation? Trends Biochem. Sci. 18:475-479.
56. Pognonec, P., and R. G. Roeder. 1991. Recombinant 43-kDa USF binds to DNA and activates transcription in a manner indistinguishable from that of natural 43/44-kDa USF. Mol. Cell. Biol. 11:5125-5136.
57. Prendergast, G. C., and E. B. Ziff. 1991. Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science 251:186-189.
58. Rasenwald, I. B., A. Lazaris-Karatzas, N. Sonenberg, and E. V. Schmidt. 1993. Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E. Mol. Cell. Biol. 13:7358-7363.
59. Rosenwald, I. B., D. B. Rhoads, L. D. Callanan, K. J. Isselbacher, and E. V. Schmidt. 1993. Increased expression of eukaryotic translation initiation factors eIF4E and eIF-2 alpha in response to growth induction by c-myc. Proc. Natl. Acad. Sci. USA 90:6175-6178.
60. Roy, A. L., C. Carruthers, T. Gutjahr, and R. G. Roeder. 1993. Direct role for Myc in transcription initiation mediated by interactions with TFII-I. Nature (London) 365:359-361.
61. Roy, A. L., M. Meisterernst, P. Pognonec, and R. G. Roeder. 1991. Cooperative interaction of an initiator-binding transcription initiation factor and the helix-loop-helix activator USF. Nature (London) 354:245-248.
62. Rychlik, W., L. L. Domier, P. R. Gardner, G. M. Hellmann, and R. E. Rhoads. 1987. Amino acid sequence of the mRNA cap-binding protein from human tissues. Proc. Natl. Acad. Sci. USA 84:945-949.
63. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed., vol. 1-3. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
64. Sawadogo, M. 1988. Multiple forms of the human gene-specific transcription factor USF. II. DNA binding properties and transcriptional activity of the purified HeLa USF. J. Biol. Chem. 263:11994-12001.
65. Sawadogo, M., and R. G. Roeder. 1985. Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box region. Cell 43:165-175.
66. Schmidt, E. V, P. K. Pattengale, L. Weir, and P. Leder. 1988. Transgenic mice hearing the human c-myc gene activated by an immunoglobulin enhancer: a pre-B-cell lymphoma model. Proc. Natl. Acad. Sci. USA 85:6047-6051.
67. Sirito, M., Q. Lin, T. Maity, and M. Sawadogo. 1994. Ubiquitous expression of the 43- and 44-kDa forms of transcription factor USF in mammalian cells. Nucleic Acids Res. 22:427-433.
68. Sklar, M. D., E. Thompson, M. J. Welsh, M. Liebert, J. Harney, H. B. Grossman, M. Smith, and E. V. Prochownik. 1991. Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells. Mol. Cell. Biol. 11:3699-3710.
69. Sonenberg, N. 1993. Translation factors as effectors of cell growth and tumorigenesis. Curr. Opin. Cell Biol. 5:955-960.
70. Spencer, C. A., and M. Groudine. 1991. Control of c-myc regulation in normal and neoplastic cells. Adv. Cancer Res. 56:1-48.
71. Stewart, T. A., P. K. Pattengale, and P. Leder. 1984. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38:627-637.
72. Stone, J., T. de Lange, G. Ramsay, E. Jakobovits, J. M. Bishop, H. Varmus, and W. Lee. 1987. Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol. Cell. Biol. 7:1697-1709.